福元医药：10月28日召开董事会会议

Group 1 - The company, Fuyuan Pharmaceutical, announced the convening of its third board meeting on October 28, 2025, to discuss the senior management compensation plan [1] - For the fiscal year 2024, the revenue composition of Fuyuan Pharmaceutical is as follows: 93.12% from pharmaceutical preparations, 6.46% from medical devices, 0.36% from other businesses, and 0.06% from other sources [1] - As of the report date, Fuyuan Pharmaceutical has a market capitalization of 10.6 billion yuan [1]